November 2021: We are celebrating our 6th year since the launch of our Hialurom portfolio. Five years on the German market with a consistent commercial growth and brand awareness since November 2016.
March 2021: actrevo GmbH and Holopack Verpackungstechnik GmbH are proud to announce a strategic partnership to combine Holopack's CMO activities with actrevo's development capacities for liquid pharmaceutical dosage forms.
October 2019: After the successful EU-GMP registration of our laboratory through the local authorities we can now provide you EU-release services.
September 2019: We are happy to announce the successful Europe-wide approval of Fulvestrant pre-filled syringes.
September 4th, 2018: actrevo GmbH and our partner BioQ Pharma will be participating at HAI 2018 in Berlin, September 20-21. Find us at booth No. 40 to learn more about us.
We would also like to invite all interested anesthesiologists and visitors to discuss the treatment of postoperative pain with local anesthetics at our HAI satellite symposium: Wie können postoperative Schmerzen erfolgreich opioidsparend behandelt werden?
Friday, September 21, 10 – 11:30 am, room 5
June 2018: We are proud to announce that to this date the actrevo team successfully guided 2 Korean companies through their first
EU GMP inspection. We will continue to provide our expertise and experience and support our partners to access the international human and veterinary healthcare market.
February 14, 2017: actrevo is going to participate at DCAT Week 2017 in New York (March 20-23); https://www.dcat.org/DCATWeek.htm
January 1st, 2017: Establishment of own pharmaceutical development laboratory in Hamburg
May 05th, 2016: 1st birthday actrevo GmbH